 |
|
|
|
Childhood "Top Dogs" Enjoy Better Health As Adults Children who are popular and wield power among their school classmates enjoy better health as adults, suggests research published ahead of print in the Journal of Epidemiology and Community Health. The authors base their findings on more than 14,000 children who were born in Sweden in 1953 and who were part of the Stockholm Birth Cohort Study. |
Sorafenib/Capecitabine Combo Boosts Progression-Free Survival In Advanced Breast Cancer BERLIN - The potent oral multiple kinase inhibitor sorafenib (NexavarR) combined with the chemotherapy drug capecitabine (XelodaR) significantly improves progression-free survival (PFS) over capecitabine alone in patients with locally advanced or metastatic HER-2 negative breast cancer, according to |
New research presented this month at a major European Oncology meeting has shown previously untreated patients who received the targeted cancer drug Erbitux (cetuximab) along with either FOLFIRI or FOLFOX4 chemotherapy lived up to 4 months longer than patients receiving just the chemotherapy. Patients had cancers showing a particular genetic make-up that responds well to treatment. |
How Living Conditions Impact Reproductive Health When costs outweigh benefits, successful pregnancies are less likely to occur. Life is all about tradeoffs and recently published research by Virginia J. |
Sciele Pharma, Inc., a Shionogi company, announced that it has submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for glycopyrrolate oral solution to treat chronic, moderate-to-severe drooling in pediatric patients. This condition often results from cerebral palsy as well as from other neurological disorders. |
Public Option Issue Likely To Face Tuesday Senate Finance Vote The Senate Finance Committee is likely to vote when it reconvenes Tuesday on inclusion of a government-run public option for health insurance. |
 |
 |
 |
